Matthew Hartog1, Qing-Yu Zhang2,3, Xinxin Ding1,2,3. 1. College of Nanoscale Science and Engineering, SUNY Polytechnic Institute, Albany, NY. 2. Wadsworth Center, New York State Department of Health, Albany, NY. 3. Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson.
Abstract
BACKGROUND: Many constituents of tobacco smoke (TS) require bioactivation to exert toxic effects; however, few studies have examined the role of bioactivation enzymes in the adverse effects of TS exposure. This knowledge gap is a major source of uncertainty for risk assessment and chemoprevention efforts. OBJECTIVES: Our aim is to test the hypothesis that cytochrome P450 (P450) enzyme mediated bioactivation is essential to the development of TS exposure-induced lung toxicity, by determining the contributions of P450 enzymes in the mouse Cyp2abfgs gene subfamilies to environmental tobacco smoke (ETS)-induced lung inflammation. METHODS: Adult female wildtype (WT) and Cyp2abfgs-null mice (both on C57BL/6J background) were exposed to filtered air or ETS, intermittently, for 1 or 2 weeks. Lung inflammation was assessed by quantification of inflammatory cells, cytokines, chemokines, proteins in bronchoalveolar lavage fluid (BALF), and histopathological analysis. Glutathione (GSH) conjugates of two ETS constituents, naphthalene (NA) and 3-methylindole (3MI), were measured in mice exposed to ETS for four hours. RESULTS: Persistent macrophagic and neutrophilic lung inflammation was observed in ETS-exposed WT mice; the extent of which was significantly reduced in ETS-exposed Cyp2abfgs-null mice. Levels of proinflammatory cytokines and chemokines, along with the total protein concentration, were increased in cell-free BALF from ETS-exposed WT mice, but not Cyp2abfgs-null mice. Additionally, GSH-conjugates of NA and 3MI were detected in the lungs of WT, but not Cyp2abfgs-null, mice following ETS exposure. CONCLUSIONS: These results provide the first in vivo evidence that the mouse Cyp2abfgs gene cluster plays an important role in ETS-induced lung inflammation.
BACKGROUND: Many constituents of tobacco smoke (TS) require bioactivation to exert toxic effects; however, few studies have examined the role of bioactivation enzymes in the adverse effects of TS exposure. This knowledge gap is a major source of uncertainty for risk assessment and chemoprevention efforts. OBJECTIVES: Our aim is to test the hypothesis that cytochrome P450 (P450) enzyme mediated bioactivation is essential to the development of TS exposure-induced lung toxicity, by determining the contributions of P450 enzymes in the mouse Cyp2abfgs gene subfamilies to environmental tobacco smoke (ETS)-induced lung inflammation. METHODS: Adult female wildtype (WT) and Cyp2abfgs-null mice (both on C57BL/6J background) were exposed to filtered air or ETS, intermittently, for 1 or 2 weeks. Lung inflammation was assessed by quantification of inflammatory cells, cytokines, chemokines, proteins in bronchoalveolar lavage fluid (BALF), and histopathological analysis. Glutathione (GSH) conjugates of two ETS constituents, naphthalene (NA) and 3-methylindole (3MI), were measured in mice exposed to ETS for four hours. RESULTS: Persistent macrophagic and neutrophilic lung inflammation was observed in ETS-exposed WT mice; the extent of which was significantly reduced in ETS-exposed Cyp2abfgs-null mice. Levels of proinflammatory cytokines and chemokines, along with the total protein concentration, were increased in cell-free BALF from ETS-exposed WT mice, but not Cyp2abfgs-null mice. Additionally, GSH-conjugates of NA and 3MI were detected in the lungs of WT, but not Cyp2abfgs-null, mice following ETS exposure. CONCLUSIONS: These results provide the first in vivo evidence that the mouse Cyp2abfgs gene cluster plays an important role in ETS-induced lung inflammation.
Authors: Hiroyuki Takahashi; Hisanobu Ogata; Reiko Nishigaki; David H Broide; Michael Karin Journal: Cancer Cell Date: 2010-01-19 Impact factor: 31.743
Authors: Andrew J Ghio; Elizabeth D Hilborn; Jacqueline G Stonehuerner; Lisa A Dailey; Jacqueline D Carter; Judy H Richards; Kay M Crissman; Robert F Foronjy; Dale L Uyeminami; Kent E Pinkerton Journal: Am J Respir Crit Care Med Date: 2008-08-21 Impact factor: 21.405
Authors: Rajinder Singh; Margaret Gaskell; Rachel C Le Pla; Balvinder Kaur; Ali Azim-Araghi; Jonathan Roach; George Koukouves; Vassilis L Souliotis; Soterios A Kyrtopoulos; Peter B Farmer Journal: Chem Res Toxicol Date: 2006-06 Impact factor: 3.739
Authors: Felix R Stahl; Katrin Heller; Stephan Halle; Kirsten A Keyser; Andreas Busche; Anja Marquardt; Karen Wagner; Jasmin Boelter; Yvonne Bischoff; Elisabeth Kremmer; Ramon Arens; Martin Messerle; Reinhold Förster Journal: PLoS Pathog Date: 2013-12-12 Impact factor: 6.823
Authors: Monica L Vermillion Maier; Lisbeth K Siddens; Sandra L Uesugi; Jaewoo Choi; Scott W Leonard; Jamie M Pennington; Susan C Tilton; Jordan N Smith; Emily Ho; H H Sherry Chow; Bach D Nguyen; Siva K Kolluri; David E Williams Journal: Drug Metab Dispos Date: 2021-05-25 Impact factor: 3.579